Moslemi Amir, Makimoto Kalysta, Tan Wan C, Bourbeau Jean, Hogg James C, Coxson Harvey O, Kirby Miranda
Department of Physics, Toronto Metropolitan University, Toronto, ON, Canada.
Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.
Acad Radiol. 2023 Apr;30(4):707-716. doi: 10.1016/j.acra.2022.05.009. Epub 2022 Jun 8.
Predicting increased risk of future healthcare utilization in chronic obstructive pulmonary disease (COPD) patients is an important goal for improving patient management.
Our objective was to determine the importance of computed tomography (CT) lung imaging measurements relative to other demographic and clinical measurements for predicting future health services use with machine learning in COPD.
In this retrospective study, lung function measurements and chest CT images were acquired from Canadian Cohort of Obstructive Lung Disease study participants from 2010 to 2017 (https://clinicaltrials.gov, NCT00920348). Up to two follow-up visits (1.5- and 3-year follow-up) were performed and participants were asked for details related to healthcare utilization. Healthcare utilization was defined as any COPD hospitalization or emergency room visit due to respiratory problems in the 12 months prior to the follow-up visits. CT analysis was performed (VIDA Diagnostics Inc.); a total of 108 CT quantitative emphysema, airway and vascular measurements were investigated. A hybrid feature selection method with support vector machine classifier was used to predict healthcare utilization. Performance was determined using accuracy, F1-measure and area under the receiver operating characteristic curve (AUC) and Matthews's correlation coefficient (MC).
Of the 527 COPD participants evaluated, 179 (35%) used healthcare services at follow-up. There were no significant differences between the participants with or without healthcare utilization at follow-up for age (p = 0.50), sex (p = 0.44), BMI (p = 0.05) or pack-years (p = 0.76). The accuracy for predicting subsequent healthcare utilization was 80% ± 3% (F1-measure = 74%, AUC = 0.80, MC = 0.6) when all measurements were considered, 76% ± 6% (F1-measure = 72%, AUC = 0.77, MC = 0.55) for CT measurements alone and 65% ± 5% (F1-measure = 60%, AUC = 0.67, MC = 0.34) for demographic and lung function measurements alone.
The combination of CT lung imaging and conventional measurements leads to greater prediction accuracy of subsequent health services use than conventional measurements alone, and may provide needed prognostic information for patients suffering from COPD.
预测慢性阻塞性肺疾病(COPD)患者未来医疗服务利用风险的增加是改善患者管理的一个重要目标。
我们的目的是确定计算机断层扫描(CT)肺部成像测量相对于其他人口统计学和临床测量在通过机器学习预测COPD患者未来医疗服务使用方面的重要性。
在这项回顾性研究中,从2010年至2017年加拿大阻塞性肺疾病队列研究参与者中获取肺功能测量值和胸部CT图像(https://clinicaltrials.gov,NCT00920348)。进行了多达两次随访(1.5年和3年随访),并询问参与者与医疗服务利用相关的详细信息。医疗服务利用定义为随访前12个月内因呼吸问题导致的任何COPD住院或急诊就诊。进行了CT分析(VIDA诊断公司);共研究了108项CT定量肺气肿、气道和血管测量值。使用支持向量机分类器的混合特征选择方法来预测医疗服务利用情况。使用准确率、F1值、受试者工作特征曲线下面积(AUC)和马修斯相关系数(MC)来确定性能。
在评估的527名COPD参与者中,179名(35%)在随访时使用了医疗服务。随访时使用或未使用医疗服务的参与者在年龄(p = 0.50)、性别(p = 0.44)、体重指数(p = 0.05)或吸烟包年数(p = 0.76)方面无显著差异。当考虑所有测量值时,预测后续医疗服务利用的准确率为80%±3%(F1值 = 74%,AUC = 0.80,MC = 0.6),仅CT测量值时为76%±6%(F1值 = 72%,AUC = 0.77),MC = 0.55),仅人口统计学和肺功能测量值时为65%±5%(F1值 = 60%,AUC = 0.67,MC = 0.34)。
与单独的传统测量相比,CT肺部成像与传统测量相结合能更准确地预测后续医疗服务的使用情况,并可能为COPD患者提供所需的预后信息。